Health Care [ 12/12 ] | Biotechnology [ 62/74 ]
NASDAQ | Common Stock
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function.
The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.
Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases.
Histogen Inc. was founded in 2007 and is based in San Diego, California.
On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in theU. S.
Bankruptcy Court for the Southern District of California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 9, 23 | -0.90 Increased by +10.89% | -0.54 Decreased by -66.67% |
| Aug 10, 23 | -0.49 Increased by +68.39% | -0.90 Increased by +45.56% |
| May 11, 23 | -0.81 Decreased by -305.00% | -0.76 Decreased by -6.58% |
| Mar 9, 23 | -0.61 Increased by +56.43% | -0.79 Increased by +22.78% |
| Nov 10, 22 | -1.01 Increased by +43.89% | -1.26 Increased by +19.84% |
| Aug 11, 22 | -1.55 Increased by +22.50% | -1.70 Increased by +8.82% |
| May 12, 22 | -0.20 Increased by +92.86% | -1.50 Increased by +86.67% |
| Mar 10, 22 | -1.40 Increased by +73.08% | -2.10 Increased by +33.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 5.00 K Increased by 0.00% | -3.85 M Decreased by -7.09% | Decreased by -77.02 K% Decreased by -7.09% |
| Jun 30, 23 | 5.00 K Increased by 0.00% | -2.09 M Increased by +38.25% | Decreased by -41.84 K% Increased by +38.25% |
| Mar 31, 23 | 5.00 K Decreased by -99.87% | -3.47 M Decreased by -415.28% | Decreased by -69.46 K% Decreased by -386.88 K% |
| Dec 31, 22 | 4.00 K Decreased by -20.00% | -2.99 M Increased by +4.72% | Decreased by -74.67 K% Decreased by -19.10% |
| Sep 30, 22 | 5.00 K Decreased by -99.15% | -3.60 M Increased by +6.38% | Decreased by -71.92 K% Decreased by -10.97 K% |
| Jun 30, 22 | 5.00 K Increased by 0.00% | -3.39 M Increased by +8.53% | Decreased by -67.76 K% Increased by +8.53% |
| Mar 31, 22 | 3.75 M Increased by +1.08 K% | -674.00 K Increased by +84.22% | Decreased by -17.95% Increased by +98.66% |
| Dec 31, 21 | 5.00 K Decreased by -98.95% | -3.13 M Increased by +10.63% | Decreased by -62.70 K% Decreased by -8.44 K% |